Financials
- Market Capitalization 1.63 B
- Employee 23
- Founded 2007
- CEO N/A
- Website www.fortebiorx.com
- Headquarter Delaware, United States
- FIGI BBG001J2N4H0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2141 | ANAB AnaptysBio, Inc. - Common Stock | 57.29 USD | -1.22% | +0.10% | +9.50% | +62.76% | 1.67 B USD | ||
| 2146 | BCAX Bicara Therapeutics Inc. - Common Stock | 24.83 USD | +0.40% | +0.40% | -7.63% | +71.95% | 1.64 B USD | ||
| 2160 | ABSI Absci Corporation - Common Stock | 9.42 USD | +2.17% | -1.46% | +33.05% | +281.38% | 1.62 B USD | ||
| 2173 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.60 USD | -0.92% | -0.12% | +4.50% | +8.72% | 1.57 B USD |
Frequently asked questions about Forte Biosciences, Inc. Common Stock
What is the Forte Biosciences, Inc. Common Stock stock price today?
The current price of Forte Biosciences, Inc. Common Stock (FBRX) is 76.99. Over the past 24 hours, the stock has changed by +0.03%. Follow the FBRX chart for real-time price dynamics.
What is the stock ticker of Forte Biosciences, Inc. Common Stock?
Forte Biosciences, Inc. Common Stock trades under the ticker FBRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Forte Biosciences, Inc. Common Stock stock going up?
FBRX has changed by +0.08% over the last week, +0.50% over the last month, and +162.32% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Forte Biosciences, Inc. Common Stock?
Forte Biosciences, Inc. Common Stock currently has a market capitalization of 1.63 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Forte Biosciences, Inc. Common Stock earnings last quarter?
Last quarter, Forte Biosciences, Inc. Common Stock reported earnings of -0.97 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Forte Biosciences, Inc. Common Stock net income for the last quarter?
Forte Biosciences, Inc. Common Stock reported net income of -23.33 M for the last quarter. The previous quarter showed -22.14 M, which means net income changed by -5.40%.
How many employees does Forte Biosciences, Inc. Common Stock have?
As of the latest available data, Forte Biosciences, Inc. Common Stock has 23 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Forte Biosciences, Inc. Common Stock stock?
You can buy Forte Biosciences, Inc. Common Stock (FBRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Forte Biosciences, Inc. Common Stock stock?
Investing in Forte Biosciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FBRX chart and related analysis on metatrader.com as part of your research.